A new weight loss drug target could lower appetite and increase energy expenditure without causing nausea as a side effect.

The discovery could lead to a new treatment for millions of people with obesity and type 2 diabetes who do not respond well to current treatments.

Dr Hilary Jones has shared an easy tip to help prevent the spread of the norovirus, as cases have spiked by a worrying 30 ...

What Nick said broke my heart and I was almost grateful for the magical thinking that an eight-year-old can employ.

A 'massive foodie' claims she woke up one day to find she was unable to eat and lost nearly half her body weight in just six months - ...

In good news for those averse to injections, GLP-1 agonist medication is a step closer to being offered in oral pill form, ...

Research shows that 1 in 8 adults in the US has used one of the popular GLP-1 medications, most of them trying to manage ...

Davina McCall has undergone brain surgery for a non-cancerous tumour, she revealed today. In a video posted on Instagram, the ...

A new Northbrook pharma will work to bring its obesity treatment to market that it says holds advantages over Ozempic and its ...

For most people diagnosed with diabetes, the desirable A1C goal is seven percent or less as higher levels are linked to ...

Danziten is a twice daily, oral medication that inhibits the BCR-ABL tyrosine kinase. Nilotinib was originally approved under the brand name Tasigna; it is currently indicated for adults and pediatric ...